EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Magnesium sulphate reduces tertiary gliosis but does not improve EEG recovery or white or grey matter cell survival after asphyxia in preterm fetal sheep

Robert Galinsky iD, Simerdeep K Dhillon, Sharmony B Kelly, Guido Wassink, Joanne O Davidson iD, Christopher A Lear iD, Lotte G van den Heuij, Laura Bennet iD, Alistair J Gunn iD

The Journal of Physiology · 2023

DOI: 10.1113/jp284381 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Physiology, 2023. Verfasst von Robert Galinsky und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, University of Auckland, Auckland, New Zealand. Hauptthemen laut MEDLINE: Premature Birth, White Matter. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Health Research Council of New Zealand, Auckland Medical Research Foundation, National Health and Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Maternal magnesium sulphate (MgSO 4 ) treatment is widely recommended before preterm birth for neuroprotection. However, this is controversial because there is limited evidence that MgSO 4 provides long‐term neuroprotection. Preterm fetal sheep (104 days gestation; term is 147 days) were assigned randomly to receive sham occlusion with saline infusion ( n = 6) or i.v. infusion with MgSO 4 ( n = 7) or vehicle (saline, n = 6) from 24 h before hypoxia–ischaemia induced by umbilical cord occlusion until 24 h after occlusion. Sheep were killed after 21 days of recovery, for fetal brain histology. Functionally, MgSO 4 did not improve long‐term EEG recovery. Histologically, in the premotor cortex and striatum, MgSO 4 infusion attenuated post‐occlusion astrocytosis (GFAP + ) and microgliosis but did not affect numbers of amoeboid microglia or improve neuronal survival. In the periventricular and intragyral white matter, MgSO 4 was associated with fewer total (Olig‐2 + ) oligodendrocytes compared with vehicle + occlusion. Numbers of mature (CC1 + ) oligodendrocytes were reduced to a similar extent in both occlusion groups compared with sham occlusion. In contrast, MgSO 4 was associated with an intermediate improvement in myelin density in the intragyral and periventricular white matter tracts. In conclusion, a clinically comparable dose of MgSO 4 was associated with moderate improvements in white and grey matter gliosis and myelin density but did not improve EEG maturation or neuronal or oligodendrocyte survival. image Key points Magnesium sulphate is widely recommended before preterm birth for neuroprotection; however, there is limited evidence that magnesium sulphate provides long‐term neuroprotection. In preterm fetal sheep exposed to hypoxia–ischaemia (HI), MgSO 4 was associated with attenuated astrocytosis and microgliosis in the premotor cortex and striatum but did not improve neuronal survival after recovery to term‐equivalent age, 21 days after HI. Magnesium sulphate was associated with loss of total oligodendrocytes in the periventricular and intragyral white matter tracts, whereas mature, myelinating oligodendrocytes were reduced to a similar extent in both occlusion groups. In the same regions, MgSO 4 was associated with an intermediate improvement in myelin density. Functionally, MgSO 4 did not improve long‐term recovery of EEG power, frequency or sleep stage cycling. A clinically comparable dose of MgSO 4 was associated with moderate improvements in white and grey matter gliosis and myelin density but did not improve EEG maturation or neuronal or oligodendrocyte survival.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Premature BirthWhite MatterInfant, NewbornHumansFemaleSheepAnimalsGray MatterAsphyxiaMagnesium SulfateGliosisCell SurvivalElectroencephalographyIschemiaHypoxia

Stichwörter der Autor:innen

asphyxiabrainmagnesium sulphateneuroprotectionpreterm birth

Substanzen

Magnesium Sulfate

Autor:innen und Institutionen

  • Department of Physiology, University of Auckland, Auckland, New Zealand.
  • The Ritchie Centre, Hudson Institute of Medical Research, Clayton, Victoria, Australia.
  • Department of Obstetrics and Gynaecology, Monash University, Victoria, Australia.

ORCID-Profile: Robert Galinsky, Joanne O Davidson, Christopher A Lear, Laura Bennet, Alistair J Gunn

Förderung

  • Health Research Council of New Zealand
  • Auckland Medical Research Foundation
  • National Health and Medical Research Council

Zitieren

APA

Galinsky, R., Dhillon, S. K., Kelly, S. B., Wassink, G., Davidson, J. O., Lear, C. A., van den Heuij, L. G., Bennet, L., & Gunn, A. J. (2023). Magnesium sulphate reduces tertiary gliosis but does not improve EEG recovery or white or grey matter cell survival after asphyxia in preterm fetal sheep. The Journal of Physiology. https://doi.org/10.1113/jp284381

Vancouver

Galinsky R, Dhillon SK, Kelly SB, Wassink G, Davidson JO, Lear CA, et al. Magnesium sulphate reduces tertiary gliosis but does not improve EEG recovery or white or grey matter cell survival after asphyxia in preterm fetal sheep. The Journal of Physiology. 2023. doi:10.1113/jp284381

BibTeX
@article{Galinsky2023,
  author = {Galinsky, Robert and Dhillon, Simerdeep K and Kelly, Sharmony B and Wassink, Guido and Davidson, Joanne O and Lear, Christopher A and van den Heuij, Lotte G and Bennet, Laura and Gunn, Alistair J},
  title = {Magnesium sulphate reduces tertiary gliosis but does not improve EEG recovery or white or grey matter cell survival after asphyxia in preterm fetal sheep},
  journal = {The Journal of Physiology},
  year = {2023},
  doi = {10.1113/jp284381}
}
Kostenlos starten →